NCT00245635.

Trial name or title	Fluoxetine in Pediatric Body Dysmorphic Disorder
Methods	Interventional, Treatment, Randomized, Double‐Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Participants	10‐16 years of age with a diagnosis of BDD, expected enrollment of 37
Interventions	Fluoxetine versus placebo x 14 weeks
Outcomes	No information
Starting date	November 2004
Contact information	Suah Kim, tel: (212) 369‐5123, suah.kim@mssm.edu
Notes	Study ID numbers ‐ GCO#02‐1020 ; FD‐R‐002337